Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will there be a generic loreev available?Pramlintide approval date?Is allopurinol expensive?Motegrity ingredients?Sun pharma bortezomib?
See the DrugPatentWatch profile for cosentyx
Yes, Cosentyx (secukinumab) is FDA-approved for active ankylosing spondylitis in adults.[1][2] It targets interleukin-17A to reduce inflammation and symptoms like back pain and stiffness. Clinical trials showed significant improvement in ASAS20 response rates compared to placebo.[2] The standard dose is 150 mg subcutaneous injection every 4 weeks after initial loading doses.[1] Sources [1]: FDA Label for Cosentyx [2]: Novartis Cosentyx Prescribing Information
Other Questions About Cosentyx :